Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Jefferies Maintains Buy on Haemonetics, Lowers Price Target to $85

Jefferies analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and lowers the price target from $105 to $85.

byBenzinga Newsdesk

May 14, 2021

1 minute read

Jefferies analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and lowers the price target from $105 to $85.

Ocwen Financial Earnings Conference Call Is Coming Up, Here’s What You Need To Know

By Benzinga Insights

Today, 10:45 PM

Ocwen Financial (NYSE:OCN) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Ocwen Financial (OCN) Conference Call Follow this link to access the live webcast.

OCN

B of A Securities Maintains Underperform on Gap, Lowers Price Target to $8

By Benzinga Newsdesk

Today, 10:45 PM

B of A Securities analyst Lorraine Hutchinson maintains Gap (NYSE:GPS) with a Underperform and lowers the price target from $9.6 to $8.

GPS

Earnings

Return on Capital Employed Insights for Jazz Pharmaceuticals

By Benzinga Insights

Today, 10:45 PM

After pulling data from Benzinga Pro it seems like during Q2, Jazz Pharmaceuticals (NASDAQ:JAZZ) brought in sales totaling $751.81 million. However, earnings decreased 142.93%, resulting in a loss of $69.59 million.

JAZZ